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Abstract: The aim of this study was to determine the seroprevalence and serotype-specificity of the circulating
antibodies against Foot-and-Mouth Disease Virus (FM DV) in cattle in K asese  and Bushenyi districts in
Uganda. A total of 309 serum samples were collected and tested for antibodies against Non-Structural (NS) and
Structural Proteins (SP) using Ceditest® FMDV-NS and Ceditest®  FMDV type O test kits. Seroprevalences
were much higher in Kasese in both tests (61 and 43%, respectively) than in Bushenyi (3 and 4%, respectively).
A high proportion of sera, that tested positive in  the NSP test, were subjected to seven serotype specific
blocking ELISAs for antibodies against the seven FMDV serotypes (O, A, C, Asia 1, SAT 1, SAT 2 and SAT
3). The study showed presence of antibodies against four FMDV serotypes with decreasing magnitude as
follows: O> SAT 1> SAT 3/SAT 2. It is recommended to develop sampling schemes to include virus recovery
and identification, as well as to focus serum sampling on young unvaccinated stock.
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INTRODUCTION
Foot-and-M outh Disease Virus (FMDV) is classified
within  the Aphthovirus genus as a member of the
Picornaviridae family and is a highly infectious disease
agent that causes severe vesicular disease. Foot-and-
Mouth Disease (FMD) affects all cloven-hoofed animals
including domesticated ruminants and pigs and more than
70 wildlife species (Thomson, 1995). The epidemiology
of FMD in Africa was reviewed by Vosloo et al. (2002)
a decade ago. The salient features of this disease in Africa
that were highlighted include; the presence of six FMDV
serotypes including serotypes O, A, C, Southern African
Territories (SAT) 1, SAT 2 and SAT 3 with only  Asia 1
serotype reported negative on the continent. The disease
is of high economic importance especially to countries
that have an intensive animal industry. 
FMD outbreaks occur annually in Uganda’s
estimated   11.4   million   cattle   population
(Anonymous, 2009), and previous studies have shown
incursions of serotypes O, A, SAT 1 and SAT 3 (Vosloo
et al., 2002). Efforts to control the disease mainly consist
of vaccination and restriction of animal movement in the
affected areas. Between 2003 and 2006 FMDV vaccines
used have included serotypes O, SAT 1 and SAT 2, and
have mainly been imported from Kenya and Botswana.
How ever, these control measures have not stopped the
FMD outbreaks, which in 2006 were mostly caused by
serotype O (Ayebazibwe et al., 2010), but also with
evidence of some SAT outbreaks in 2004 and 2006
(Balinda et al., 2009a; Ayebazibwe et al., 2010). 
Several techniques for confirmation of FMDV have
been described in the OIE Manual of Diagnostic
Techniques (OIE, 2004) but there is still need for
considerable effort for developing rapid, accurate tests for
use on a wider scale (Clavijo et al., 2004). FMDV can be
isolated from cell cultures, or the viral antigen can be
detected using ELISAs, while the presence of viral
genomic material can be detected using RT-PCR assays.
Serological assays for the detection of antibodies against
FMDV, irrespective of infection or vaccination status in
animals,   have   been   applied   in   many  studies
(Berger et al., 1990; Have and Jensen, 1983; Sorensen et
al., 1998a), however, these first antibody test systems
were serotype-specific, and thus tedious to use for
screening in areas where multiple FMD V serotypes are
present. Albeit developed with a different scope
(Sorensen et al., 2005), the development of serological
tests using the FM DV Non-Structural   Proteins   (NSP),
which  have  shared epitopes between the serotypes, has
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Fig. 1: Map of Uganda showing the districts included in this study
provided a much needed tool for detection of antibodies
against FMDV in areas with concurrent activity of more
serotypes. Recently, another test system using the
structural  proteins  of  serotype  O  has  been  developed
to    detect    antibodies    against    serotypes    O
(Chénard et al., 2003). This ELISA has been shown to
have cross serotype specific ity  against FMD serotypes A,
C and Asia 1, however, the sensitivity of this test for
antibodies against serotypes SAT 1, SAT 2 and SAT 3
has, as far as we know, never been evaluated.  
The aim of this study was to determine the
seroprevalence and serotype-specificity of the circulating
antibodies against FMDV in cattle in Kasese and
Bushenyi districts in Uganda.
MATERIALS AND METHODS
Study area, sampling, sample collection and handling:
This study was carried out between April and June 2007
in two Western Uganda districts: Kasese district, which is
often involved in FMD outbreaks and harbors Queen
Elizabeth National Park (QENP), and Bushenyi district,
which, despite harboring a wildlife reservoir for QENP
and bordering this park, has not reported FMD-outbreaks
for 10 years, except for a quickly contained outbreak in
2006 (Fig. 1). The farmers in Kasese District
predominantly practice communal grazing, while fencing
or paddock grazing is mainly practiced in Bushenyi. The
counties in these districts were selected for inclusion in
the study based on information from the District
Veterinary Officers’ (DVOs) to the Ministry of
Agriculture Animal Industry and Fisheries (MAAIF) on
suspected FMD outbreaks. The herds w ere selected based
on consultation with field veterinary officers in the
respective districts on investigation of recent FMD
outbreaks. The farmers were interviewed about
management practice, other animals grazing with cattle,
previous exposures to FMDV and vaccination history.
With the consent of the farmers, cattle blood samples
were taken. Serum was extracted in the field within 24 h
of sampling by use of a Mobilespin 12-V field centrifuge
(Vulcon Technologies, UK). Aliquots of approximately
4.5 mL of sera were collected, transported on ice and
stored at -20ºC at the National Animal Disease
Diagnostics and Epidemiology Centre (NA DDEC) until
needed for serological analysis. A total of 309 cattle sera
from 36 herds were collected and analyzed for antibodies
against FMDV. 
Serological investigation of antibodies against FMDV:
All sera were screened for antibodies against FMDV Non-
Structural Proteins (NSP) using Ceditest® FMDV-NS kit
(Cedi  Diagnostics  BV, Lelystad, The Netherlands) and
against   Structural  Proteins  (SP)  of FMDV serotype O
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SP-O) using Ceditest® FMDV type O kit (Cedi
Diagnostics BV, Lelystad, The Netherlands). Briefly;
Ceditest® FMDV-NS kit is a blocking ELISA that detects
antibodies against the non-structural 3ABC protein of
FMDV of all seven serotypes and it may be used to detect
infection of vaccinated animals (Sorensen et al., 2005).
Standard protocol procedures were followed according to
manufacturer’s instructions. Optical Density values (OD)
w e r e  m e a s u r e d  w i t h  a  M u l t i s k a n  A s c e n t
spectrophotometer (Thermo Labsystems Oy, UK) using
dual wavelengths of 620 nm and 450 nm and Ascent
Software, version 2.6. Ceditest® FMDV type O test was
also performed according to the manufacturer’s
instructions. For both kits, the results were expressed as
Percentage Inhibition (PI) as follows; 
PI = 100 – ((OD450 - OD620)test serum/(OD450 - OD620) mean negative control)
x100 
PI <50% was interpreted as negative, while a PI value
of $50%  was positive. 
From each herd, 17-100% (average 70%) of sera that
tested  positive  on  NSP were selected and screened for
antibodies against all the seven FMDV serotypes (O, A,
C, Asia 1, SAT 1, SAT 2 and SAT 3) at a fixed dilution of
1/5 using an in-house Solid Phase Blocking ELISA
(SPBE) system set up at Lindholm (Balinda et al., 2009b)
and implemented at M AAIF. The percentage OD value,
ODP, of each individual serum was calculated as the OD
value of the test sample as a percentage of the mean OD
value of four wells with a negative control serum. The cut
off values varied between serotypes. Sera were considered
positive, if the ODP was <50% for serotypes O, SAT 1,
SAT 2 and SAT 3, <45% for type A, and <35% for
serotypes C and Asia 1 (Balinda et al., 2009b). In herds
where serotype screening show ed reactivity for multiple
serotypes in the same herd, representative sera were two-
fold diluted from 1/5 to 1/640 for one or more serotypes
as appropriate. The antibody titres were calculated as the
reciprocal of the last positive dilution in the dilution
series.
Statistical analysis: Descriptive statistics were used and
frequency  distributions  calculated  (Thrusfield and
Bertola, 2005). Prevalences of positive animals were
determined  by  dividing  the  number  of positive serum
Tab le 1: Pre valen ces of a ntibod ies again st FM DV  NS P an d FM DV  SP -O in  cattle from  36 far ms in  Ka sese an d Bu shen yi districts
No. Sera NSP SP-O L ast F M D Vaccination
District Cou nty Village Farm  ID Farm type tested P os itiv e ( %) P os itiv e ( %) outbreak date
Kasese Buso ngora Kabaka K1g Com mu nal 24 18 (75) 1 (4) July 2006 ia
  Busunga K2 s Fenced 9 9 (100) 6 (67) May and ia
August 2006
   K3 Com munal 7 7 (100) 5 (71) 2006 ia
   K4 Fenced 14 13 (93) 12 (86) 2006 ia
   K5gs Fenced 11 7 (64) 2 (18) 1974 2005
  Rw entutu K6gs Fenced 15 1 (7) 0 (0) 1974 1985
 Buk onjo Rwem byo K7gs Fenced 17 6 (35) 1 (6) 2000 October 2006
  Ka yanja K8g Com mu nal 10 6 (60) 5 (50) April and April 2007
December  2006
   K9g Com mu nal 10 9 (90) 9 (90) October 2005 April 2007
   K10 g Com mu nal 10 6 (60) 5 (50) ia ia
   K11 g Com mu nal 10 2 (20) 2 (20) ia ia
   K12 g Com mu nal 10 7 (70) 9 (90) October 2005 April 2007
  Ibuga K13 Com mu nal 10 7 (70) 6 (60) 2005 April 2007
  Kisasa K14 g Com mu nal 12 9 (75) 7 (58) November 2006 April 2007
   K15 g Com mu nal 4 3 (75) 3 (75) ia ia
   K16 g Com mu nal 20 8 (40) 10 (50) ia ia
Sub-total 193 118 (61) 83 (43)
Bushenyi Buny aruguru Mu gogo III B1 Fenced 4 0 (0) 0 (0) n nv
  Buzen ga II B2g Fenced 11 1 (9) 0 (0) 1997 nv
  Katara B3  g Fenced 6 0 (0) 0 (0) 1997 nv
 Igara (E ast) Ny akah ita B4  g Fenced 4 0 (0) 0 (0) n May 2006
  Katunda B5  g Fenced 6 1 (17) 0 (0) n May 2006
   B6  g Fenced 5 0 (0) 0 (0) n nv
  Kabushaho B7gs Fenced 4 0 (0) 0 (0) n nv
  Kihunda B8  g Fenced 11 0 (0) 1 (9) n March 2007
   B9s Fenced 5 0 (0) 2 (40) n March 2007
   B10 gs Fenced 3 0 (0) 1 (33) n March 2007
 Ruhinda Ka jwija B11 Fenced 4 0 (0) 0 (0) 1970 nv
 Sheema
(North) Kob ukyera B12  g Fenced 6 0 (0) 1 (17) n March 2007
  Ngoma B13  g Fenced 5 0 (0) 0 (0) 1970 nv
  M utojo B14  g Fenced 7 0 (0) 0 (0) n nv
   B15  g Fenced 3 0 (0) 0 (0) 1992 nv
  Kem ikyera B16  g Fenced 5 0 (0) 0 (0) 1982 nv
   B17 Fenced 7 0 (0) 0 (0) n nv
  Kim ondo II B18  g Fenced 6 1 (17) 0 (0) n nv
   B19  g Fenced 8 0 (0) 0 (0) n nv
   B20  g Fenced 6 1 (17) 0 (0) n nv
Sub-total 116 4 (3) 5 (4)
g: cattle  farm s w ith goats  only , s: cattle  farm s w ith sh eep  only , gs: cattle farms with both goats and sheep, ia: information not available, n: never had FMD  outbreak, nv: never
vaccinated
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Table 2 : Sc reen ing  at  a d ilut ion  of  1:5 o f s era f rom ca tt le  he rds in Kasese  Dis tr ic t for  se ro type -speci fi c ant ibodies  agains t FMDV 
Prop ortion o f positiv e sera p er sero type in S PB E 1:5
-----------------------------------------------------------------------------------------------------------------------------------------------------
Herd ID No. of sera screened O A C Asia1 SAT1 SAT2 SAT3
K1g 12 5/12 0/12 0/12 0/12 6/12 10/12 9/12
K2 s 9 8/9 2/9 4/9 2/9 7/9 9/9 8/9
K3 7 6/7 0/7 1/7 0/7 6/7 7/7 6/7
K4 13 13/13 1/13 0/13 0/13 5/13 7/13 12/13
K5gs 3 2/3 0/3 1/3 1/3 1/3 2/3 2/3
K6gs 1 1/1 0/1 0/1 0/1 0/1 1/1 1/1
K7gs 5 1/5 0/5 0/5 0/5 2/5 4/5 4/5
K8g 6 6/6 2/6 1/6 0/6 6/6 5/6 6/6
K9g 5 5/5 1/5 1/5 4/5 5/5 5/5 5/5
K10 g 1 1/1 0/1 0/1 0/1 1/1 1/1 1/1
K11 g 2 2/2 0/2 0/2 1/2 2/2 2/2 2/2
K12 g 2 2/2 0/2 0/2 2/2 2/2 1/2 2/2
K13 2 2/2 0/2 0/2 2/2 2/2 1/2 1/2
K14 g 4 4/4 0/4 0/4 1/4 4/4 4/4 4/4
K15 g 3 3/3 0/3 0/3 0/3 3/3 3/3 2/3
K16 g 4 4/4 1/4 0/4 0/4 4/4 3/4 4/4
Total 79 65/79 7/79 8/79 13/79 56/79 65/79 69/79
samples by the total number of samples tested. A herd
was considered positive for a given serotype if one or
more serum samples had antibody titres $160 in the
serotype-specific SPBE.
RESULTS
All herds were free from clinical signs of FMD
during sampling in 2007. The last outbreak of FMD in
these two Districts  took place in May-August 2006, 8-11
months before the sampling, and involved at least six of
the 16 sampled farms in Kasese district (Table 1), while
all of the sampled farms in Bushenyi District had been
free from FMD for a prolonged period of time.
Vaccination had been carried out 2-6 weeks before the
sampling on five Kasese farms (K8, K9, K12, K13 and
K14) (Table 1) and in two Bushenyi villages, Kihunda
(B8, B9, B10) and Kobukyera (B12). 
Prevalence of antibodies against FMDV in Kasese and
Bushenyi Districts: Only 4 out of 116 serum samples
from Buzenga II (B2), Katunda (B5) and Kimondo II
(B18, B20) villages of Bushenyi district were positive for
antibodies against NSP, while five o ther serum samples
from Kihunda (B8, B9, B10) and Kobukyera (B12)
villages of the same district were found positive for
antibodies against SP-O (Table 1).
All sixteen farms in the seven sampled villages of
Kasese district, were positive for antibodies against NSP
with altogether 61% (118/193) of serum samples testing
positive in this test, while only 43%  (83/193) were
positive for antibodies against SP-O (Table 1). On farm
level prevalences for antibodies against NSP were
generally high (60-100%), but two farms, one fenced and
one practicing communal grazing, had only 7 and 20% of
the samples positive.
Seventy-nine of the 122 sera positive for antibodies
against NSP were screened at a dilution 1:5 in the SPBE
Tab le 3: Titres in sera titrated for antibodies against FMD V serotypes O, SAT 1,
SAT 2 and SAT 3
Titre* Number of sera per FMD V serotype
----------------------------------------------------------------------------------
O SAT 1 SAT 2 SAT 3
#40 19/46 29/54 29/42 36/55
80 12/46 14/54 8/42 8/55
$160 15/46 11 /54 5 /42 11/ 55
*: Titre expressed a s the reciprocal value o f the last positive dilution. Cut-off  ³160
for  antibodies  against  all  seven  FMD V serotypes
(Table 2). Only a few sera reacted positive when screened
in the SPBE for antibodies against serotypes A, C and
Asia 1 (7, 8 and 13 of the 79 sera, respectively). These
sera had higher ODPs for one, or in most cases more, of
serotypes O, SAT 1, SAT 2 and SAT 3, and since
previous work with this SPBE test system has shown that
such  reactions  are most likely cross-reactions
(Ayebazibwe et al., 2010; Balinda et al., 2009b), these
reactions were not investigated further. 
A high proportion of the 79 tested sera were positive
in the SPBEs for antibodies against serotypes O (82%),
SAT 1 (71%), SAT 2 (82%) and SAT 3 (87%), and a
number of these were titrated in the relevant SPBEs
(46/67, 54/58, 42/66 and 55/71, respectively). High
antibody titres ($160) were found in less than one third of
the titrated sera for each of serotypes O (33%), SAT 1
(20%), SAT 3 (20%) and SAT 2 (12%) (Table 3),
altogether comprising 22 of the titrated sera, of which 12
had this level of antibodies towards two or more serotypes
(Table 4).  
Animals from the five herds in Kayanja, Ibuga and
Kisasa with a recent vaccination history (K8, K9, K12,
K13 and K14) generally displayed antibody titres of 80
and above against more than one of the following
serotypes; O, SAT 1, SAT 2 and SAT 3, while four herds
in Rwentutu, Rwembyo and Busunga had no (K5, K6 and
K7, titres # 40) or minimal (K3, one serum with titre 80
against serotype O) evidence of more recent exposure to
FMDV.
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Table 4: Serotype-specific antibody titres for serotype O, SA T 1, SAT  2 and SA T 3 in sixteen herds in Kasese district
VILLAGE Farm  ID Field ID O SAT1 SAT2 SAT3 Conclusion  (s)
Kabaka K1g 18 20 * 80 5 SAT 2 (SA T 1)
  16 nd 5 nd nd
  23 * 5 160 20
  20 * 10 nd nd
  19 * 10 nd *
  14 nd 80 nd nd
  17 nd * * 10
Busunga K2 s 28 40 nd nd 40 O, SAT1, SAT 3
  32 80 5 nd 10
  31 80 80 nd 80
  26 160 20 5 160
  33 160 320 5 160
  27 320 5 5 80
  29 nd 40 nd nd
  25 nd * nd 20
Busunga K3 34 40 40 5 40 (O)
  35 80 10 10 40
  39 * 20 20 10
  36 nd 40 nd 40
  38 nd 40 nd *
  40 nd nd 40 5
Busunga K4 44 20 20 5 40 O (SAT  1, SAT 3)
  53 40 20 * 20
  41 40 * 5 10
  51 80 * nd 5
  46 160 40 5 80
  48 320 * * 5
  45 nd 10 * nd
  47 nd 80 nd 40
Busunga K5gs 72 40 * nd nd -
  77 nd 10 nd nd
Rw entutu K6  gs 62 * * 5 5 -
Rwem byo K7  gs 86 40 20 5 10 -
  84 * 5 5 5
  88 * * * 10
  94 * * 5 5
  97 * * 5 *
Ka yanja K8  g 108 20 10 10 10 SAT 1,  SAT 3, O,  SAT 2
 100 80 320 80 160
  103 80 320 80 320
  101 80 320 * 320
  107 320 320 160 320
  99 nd 80 * 40
Ka yanja K9  g 113 10 40 20 20 O, SAT1, SAT 3,  SAT 2
  118 20 80 20 40
  109 320 320 320 320
  110 320 320 5 160
  114 320 320 160 320
Ka yanja K10  g 167 320 160 80 80 O, SAT 1 (SA T2, SAT 3)
Ka yanja K11  g 182 20 20 40 10 SAT 1,  SAT 2  (O)
  176 40 160 40 40
  175 80 80 160 20
Ka yanja K12  g 194 320 80 80 160 O, SAT 1, SAT  3 (SAT2)
189 320 320 40 80
Ibuga K13 121 80 80 40 20 (O, SAT1)
120 80 80 * nd
Kisasa k14  g 138 40 40 40 80 (SAT1, SAT 3,  SAT 2 , O)
130 40 80 80 80
136 40 80 40 80
131 80 80 80 80
Kisasa K15  g 143 20 10 5 10 SAT 3 (SA T 2)
141 40 40 80 320
142 40 40 nd *
Kisasa K16  g 156 80 80 40 40 O (SAT 1)
164 320 10 * 20
162 320 10 10 10
153 320 80 40 20
*:  negative at screening,  nd: not done, positive at screening, but not titrated , mo st ofte n du e to d eple tion  of th e sam ple, g: cattle  farm s w ith goats  only , s: cattle farm s with
she ep o nly, gs:  cattle farms with both goats and sheep 
High antibody titres against serotype O were
recorded  in  animals  in  the  remaining  two  herds from
Busunga (K2 and K4), one herd from Kayanja (K10) and
one herd from Kisasa (K16) with concurrent high (K2 and
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K10, titres $ 160) or borderline (K4 and K16, titres = 80)
titres against one or more SAT-serotypes.
High antibody titres against serotype O were absent
in the remaining three herds, while there were high titres
of antibodies against one or more of the SAT-serotypes
(K1, Kabaka: SAT 2; K11, Kayanja: SAT 1 and SAT 2;
K15, Kisasa: SAT 3) (Table 4).
DISCUSSION
The two Ugandan Districts investigated in this study
had very different status for antibodies against FMDV
with much lower seroprevalences of antibodies against
FMDV NSP and SP-O in Bushenyi, where only nine of
116 sera were positive in one of the two ELISAs, than in
Kasese, where 118 and 83 out of 193 sera were positive
for antibodies against NSP and SP-O, respectively. 
In Bushenyi, reports of vaccination on farms B8, B9,
B10 and B12 some 2-6 weeks prior to the sampling
probably accounted for the reactions in the SP-O ELISA,
however, the seroprevalences (9-40%) were surprisingly
low considering that the trivalent vaccine included
serotype O. The reactions seen in the NSP ELISA could
be left over antibodies from a rare outbreak in the usually
FMD -free Bushenyi District in 2006, or maybe evidence
of introduction of animals to this area through trade or
traditional exchange, or antibodies elicited by the non-
purified vaccines used. These serum samples were not
further investigated. A similar study in small ruminants
carried   out   simultaneously   on  the same farms
(Balinda et al., 2009b) also indicated that Bushenyi was
free from FMDV in 2007. 
In contrast, most Kasese farms had high prevalences
of antibodies against FMDV NSP (mean prevalence 61%)
as well as against FMDV SP-O (mean prevalence 43%)
compared to prevalences of antibodies towards NSP of 14
and 22% in goats and sheep, respectively, reported in the
same area by (Balinda et al., 2009b). In cattle, further
investigation of the antibodies showed that they were
directed mainly towards serotypes O, SAT 1, SAT 2 and
SAT 3, while the reactions recorded in the SPBEs for
antibodies against serotypes A, C and Asia 1 were of low
magnitude and most likely cross reactions of antibodies
against other serotypes as has previously been described
for this (Ayebazibwe et al., 2010) as well as for another
SPCE system (Mackay et al., 2001). 
Different serotype profiles were found on different
farms. The FMDV-antibody negative serological profiles
of one farm in each of Busunga, Rwembyo and Rwentutu
villages were consistent with the absence of FM D for a
prolonged period of time, and the few cases of titres 40 in
two of these herds most likely represented left over
antibodies from vaccinations in 2005 and 2006,
respectively.
Nine herds reported recent outbreaks of FM D, six in
2006 and three in 2005, and five of these herds in Ibuga,
Kayanja and Kisasa reported very recent vaccination,
while three herds in Busunga and one in Kabaka did not
report  vaccination. The  serological  profiles  in the five
vaccinated herds accorded with application of the non-
purified trivalent vaccine used in Uganda, except for high
titres of antibodies against SAT 3, which is not included
in this vaccine. One of the four herds that did not report
vaccination had an equally mixed serological profile, and
it is an open question whether this herd had actually been
vaccinated in 2007, while the remaining three farms, one
in Kabaka (K1) and two in Busunga (K3 and K4), had
serological profiles confirming the lack of vaccination and
consistent with older outbreaks of FMDV serotypes SAT
2 and O, respectively.
Of the four herds that neither reported recent FMD
outbreaks nor vaccination, two in Kayanja had mixed
serological profiles (K 10 and K11), and it is not unlikely
that these two herds like three other herds in Kayanja had
been involved in the 2006 outbreak and had been
vaccinated just before the sampling. With regard to the
remaining two herds in this group (Kisasa, K15 and K16),
serological profiles were more narrow and pointed
towards recent exposure to serotypes SAT 3 and O,
respectively. 
Presence of antibodies against FMDV in cattle was
related to presence of antibodies against FMDV in non-
vaccinated small ruminants in the same herds in the
villages of Busunga, Kabaka, Kayanja and Kisasa, and it
was concluded that small ruminants  may also be infected
during a FMD outbreak (Balinda et al., 2009b). Thus, in
addition to the known presence of live FMDV in
recovered and persistently infected cattle, these small
ruminants may constitute an unrecognized reservoir for
FMDV from w hich the infection could be transferred in
case of contact with naïve individuals.
The observed higher seroprevalences and titres of
antibodies in cattle than in sheep and goats in the same
villages was most likely due to priming of cattle by
previous vaccinations with multivalent FMDV vaccines,
maybe in combination with lower infection efficacy in
small ruminants.
The described serological profiles correlate well with
a post-outbreak study of the 2006 FMD outbreak in this
area (Ayebazibwe et al., 2010), which showed serological
evidence of exposure to FMDV serotypes O and SATs
coupled with isolation of FMDV serotype O. This FMD
outbreak took place in May-August 2006 and was
followed by a vaccination campaign in the area using
trivalent non-purified vaccines inc luding FMDV
serotypes O, SAT 1 and SAT 2 in October of the same
year and in some of the herds in April 2007.  
Non-purified vaccines as those used to control FMD
in Uganda may elicit antibodies against NSP, especially
after repeated use (Sutmoller et al., 2003), and some of
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the positive reactions in the NSP test presented in this
paper are probably due to these vaccinations. Thus, the
use of the NSP kit to distinguish infected from vaccinated
animals is not reliable in areas like Uganda, where this
type of vaccine is used.
Nevertheless, the NSP test has aided serological
diagnosis of FMD V as this test can detect antibodies
induced by any of the seven serotypes of FMDV
(Bronsvoort et al., 2006; Sorensen et al., 1998b).
Likewise, the Ceditest FMDV type O kit, which uses
purified structura l  proteins from FMDV serotype O as
antigen,   has   been  show n  to  identify  antibodies
against FMDV    serotypes    O,    A,   C   and   Asia   1
(Chénard et al., 2003). However, our data indicate that the
type O test kit may not be suitable for screening in areas
where the SAT-serotypes of FMDV are present. This is
discussed in detail by Ayebazibwe et al., (2010).
In this paper, there were concurrent high antibody
titres against serotypes O, SAT 1, SAT 2, and SAT 3 in
the same serum or herd in allegedly unvaccinated animals
(K2, K10, K11, K15 and K16). This was also observed in
Ugandan  small  ruminants  (Balinda  et  al., 2009b) and
in  a  post  outbreak  study  in Ugandan cattle
(Ayebazibwe et al., 2010). This reactivity may be due to
waning antibodies from previous outbreaks and/or non-
reported vaccinations. Low er titres (#80) may represent
cross-reactivity between the serotype-specific ELISAs
(Balinda et al., 2009b; Mackay et al., 2001). More recent
investigations on sera from experimentally vaccinated and
infected animals in these ELISAs indicate that especially
the SAT 3 antibody ELISA has a high degree of cross-
reactivity from antibodies against other serotypes
(Tjornehoj et al., Unpublished date). Thus, the high
antibody titres against serotype SAT 3 measured in this
test, including the one animal from Kisasa (K15), should
be interpreted with caution, and can at this point in time
not be regarded as conclusive evidence for infection of
Ugandan cattle with FMDV serotype SAT 3.     
In conclusion, this sampling showed high antibody
prevalences in Kasese District, while Bushenyi seemed
free from FMDV in 2007. Antibody profiles varied
between herds, but reflected the infection and vaccination
status at village or herd level. There was serological
evidence of past infection with serotypes O, SAT 1 and
SAT 2, while evidence of exposure to serotype SAT 3
was not conclusive due to perceived problems with test
specificity. It is recommended to develop the procedures
for sampling and diagnosis of FMDV to include
confirmation of viruses circulating in the area using virus
isolation, antigen ELISA and/or RT-PCR and VP1-
sequencing. It is also recommended to focus the post
outbreak sampling for serological diagnosis on young
unvaccinated stock to avoid interference from antibodies
elicited by the trivalent non-purified vaccine used in
Uganda. 
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